Sarcopenia is the degenerative loss of skeletal muscle mass, quality, and strength associated with aging.
Cachexia or wasting syndrome is loss of weight, muscle atrophy, fatigue, weakness, and significant loss of appetite in someone who is not actively trying to lose weight. Anorexia nervosa is an eating disorder characterized by immoderate food restriction and irrational fear of gaining weight, as well as a distorted body self-perception.
Our strategy is to understand the complex genetic and molecular pathways regulating muscle mass and function, as well as other disease mechanisms. Understanding the impact of complex regulatory pathways which act to build and maintain healthy lean muscle is central to our company’s pioneering biotherapeutic discovery science. This research is the foundation of our bionutritional product development. MYOS is developing nutritional products that target specific mechanisms to promote health in ways that cannot be met by other treatments, diets or lifestyle changes.